United States Biotechnology & Medical Research

Intercept Pharmaceuticals Inc (ICPT)

Track

Stock chart
Ticker: ICPT Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
AKKARAJU SRINIVAS
1 purchase — total 3,129,630 USD
Buy 12 Mar 2021
Value US$3,377,006.54 | Price 180.64 | Shares 15,114
Buy 10 Mar 2021
Value US$2,718,287.09 | Price 262.62 | Shares 94,551
Buy 10 Mar 2021
Value US$2,035,744.60 | Price 37.37 | Shares 96,772
Planned sale 5 Jan 2021
Value US$53,662.71 | Price 24.47 | Shares 2,193
Planned sale 15 Dec 2020
Value US$57,791.14 | Price 32.78 | Shares 1,763
Sale 18 Aug 2020
Value US$56,542.52 | Price 47.44 | Shares 1,192
Sale 17 Aug 2020
Value US$57,760,186.00 | Price 46.75 | Shares 1,235,512
Sale 17 Aug 2020
Value US$6,362,912.96 | Price 50.15 | Shares 126,888
Sale 17 Aug 2020
Value US$57,760,186.00 | Price 46.75 | Shares 1,235,512
Sale 17 Aug 2020
Value US$6,362,912.96 | Price 50.15 | Shares 126,888
Sale 17 Aug 2020
Value US$57,760,186.00 | Price 46.75 | Shares 1,235,512
Sale 17 Aug 2020
Value US$6,362,912.96 | Price 50.15 | Shares 126,888
Sale 14 Aug 2020
Value US$2,760,111.90 | Price 50.55 | Shares 54,600
Sale 14 Aug 2020
Value US$2,760,111.90 | Price 50.55 | Shares 54,600
Sale 14 Aug 2020
Value US$2,760,111.90 | Price 50.55 | Shares 54,600
Sale 13 Aug 2020
Value US$4,365,451.40 | Price 52.60 | Shares 83,000
Sale 13 Aug 2020
Value US$4,365,451.40 | Price 52.60 | Shares 83,000
Sale 13 Aug 2020
Value US$4,365,451.40 | Price 52.60 | Shares 83,000
Sale 13 May 2020
Value US$50,385,898.80 | Price 84.60 | Shares 595,578
Sale 13 May 2020
Value US$50,385,898.80 | Price 84.60 | Shares 595,578
Sale 13 May 2020
Value US$50,385,898.80 | Price 84.60 | Shares 595,578
Planned sale 27 Apr 2020
Value US$15,556.95 | Price 85.95 | Shares 181
Planned sale 9 Apr 2020
Value US$4,060.00 | Price 70.00 | Shares 58
Planned sale 27 Feb 2020
Value US$9,901.06 | Price 87.62 | Shares 113
Planned sale 27 Jan 2020
Value US$67,990.92 | Price 94.04 | Shares 723
Planned sale 7 Jan 2020
Value US$82,730.64 | Price 113.02 | Shares 732
Planned sale 31 Dec 2019
Value US$12,500.00 | Price 125.00 | Shares 100
Planned sale 31 Dec 2019
Value US$32,750.00 | Price 125.00 | Shares 262
Planned sale 27 Dec 2019
Value US$194,842.44 | Price 123.24 | Shares 1,581
Planned sale 26 Dec 2019
Value US$6,750.00 | Price 125.00 | Shares 54
Planned sale 26 Dec 2019
Value US$52,125.00 | Price 125.00 | Shares 417
Planned sale 19 Dec 2019
Value US$18,395.30 | Price 119.45 | Shares 154
Planned sale 27 Nov 2019
Value US$105,716.00 | Price 101.65 | Shares 1,040
Planned sale 26 Nov 2019
Value US$437,300.00 | Price 100.00 | Shares 4,373
Planned sale 26 Nov 2019
Value US$3,543,700.00 | Price 100.00 | Shares 35,437
Planned sale 25 Nov 2019
Value US$185,500.00 | Price 100.00 | Shares 1,855
Planned sale 25 Nov 2019
Value US$1,456,300.00 | Price 100.00 | Shares 14,563
Planned sale 19 Nov 2019
Value US$131,750.00 | Price 85.00 | Shares 1,550
Planned sale 19 Nov 2019
Value US$325,465.00 | Price 85.00 | Shares 3,829
Planned sale 19 Nov 2019
Value US$707,625.00 | Price 85.00 | Shares 8,325
Planned sale 13 Nov 2019
Value US$80,410.00 | Price 85.00 | Shares 946
Planned sale 13 Nov 2019
Value US$42,500.00 | Price 85.00 | Shares 500
Planned sale 29 Oct 2019
Value US$44,625.00 | Price 75.00 | Shares 595
Planned sale 23 Oct 2019
Value US$4,060.00 | Price 70.00 | Shares 58
Planned sale 16 Sep 2019
Value US$56,000.00 | Price 70.00 | Shares 800
Buy 28 Aug 2019
Value US$314,086.24 | Price 60.32 | Shares 5,207
Planned sale 3 Jul 2019
Value US$46,802.70 | Price 78.66 | Shares 595
Buy 14 May 2019
Value US$100,200.00 | Price 83.50 | Shares 1,200
Planned sale 1 May 2019
Value US$172,560.00 | Price 86.28 | Shares 2,000
Planned sale 15 Apr 2019
Value US$190,000.00 | Price 95.00 | Shares 2,000
Planned sale 3 Apr 2019
Value US$64,635.62 | Price 115.01 | Shares 562
Planned sale 3 Apr 2019
Value US$68,315.94 | Price 115.01 | Shares 594
Planned sale 29 Mar 2019
Value US$233,272.21 | Price 107.45 | Shares 2,171
Planned sale 1 Mar 2019
Value US$34,352.28 | Price 103.16 | Shares 333
Planned sale 1 Mar 2019
Value US$206,320.00 | Price 103.16 | Shares 2,000
Planned sale 19 Feb 2019
Value US$3,018,345.64 | Price 128.78 | Shares 23,438
Planned sale 15 Feb 2019
Value US$223,020.00 | Price 111.51 | Shares 2,000
Planned sale 7 Jan 2019
Value US$137,773.09 | Price 104.93 | Shares 1,313
Planned sale 4 Jan 2019
Value US$46,205.52 | Price 97.48 | Shares 474
Planned sale 3 Jan 2019
Value US$30,344.44 | Price 117.16 | Shares 259
Planned sale 3 Jan 2019
Value US$68,117.55 | Price 97.45 | Shares 699
Planned sale 2 Jan 2019
Value US$196,560.00 | Price 98.28 | Shares 2,000
Planned sale 17 Dec 2018
Value US$213,240.00 | Price 106.62 | Shares 2,000
Sale 4 Dec 2018
Value US$33,300.00 | Price 111.00 | Shares 300
Sale 3 Dec 2018
Value US$22,644.60 | Price 113.22 | Shares 200
Sale 3 Dec 2018
Value US$78,486.03 | Price 112.12 | Shares 700
Sale 3 Dec 2018
Value US$422,690.72 | Price 111.23 | Shares 3,800
Sale 29 Nov 2018
Value US$78,802,500.00 | Price 105.07 | Shares 750,000
Sale 29 Nov 2018
Value US$78,802,500.00 | Price 105.07 | Shares 750,000
Planned sale 29 Nov 2018
Value US$152,806.54 | Price 113.78 | Shares 1,343
Planned sale 16 Nov 2018
Value US$205,332.57 | Price 103.29 | Shares 1,988
Planned sale 16 Nov 2018
Value US$804,373.90 | Price 102.61 | Shares 7,839
Planned sale 16 Nov 2018
Value US$806,686.78 | Price 101.48 | Shares 7,949
Planned sale 16 Nov 2018
Value US$986,735.40 | Price 100.38 | Shares 9,830
Planned sale 15 Nov 2018
Value US$356,088.24 | Price 101.13 | Shares 3,521
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2021-03-12 2021-03-12 B Purchase
3.6
AKKARAJU SRINIVAS
Non-Executive Director
15,114 +6.7%
180.64
US$3,377,007 		15,114 +6.7% 180.64 US$3,377,007
2021-03-12 2021-03-10 B Purchase
3.6
AKKARAJU SRINIVAS
Non-Executive Director
94,551 +11.2%
262.62
US$2,718,287 		94,551 +11.2% 262.62 US$2,718,287
2021-03-12 2021-03-10 B Purchase
3.6
AKKARAJU SRINIVAS
Non-Executive Director
96,772 +40.3%
37.37
US$2,035,745 		96,772 +40.3% 37.37 US$2,035,745
2021-01-05 2021-01-05 PlS Planned sale
Kapadia Sandip

CFO and Treasurer

Officer
2,193 -8.4%
24.47
US$53,663 		2,193 -8.4% 24.47 US$53,663
2020-12-16 2020-12-15 PlS Planned sale
Kapadia Sandip

CFO and Treasurer

Officer
1,763 -6.1%
32.78
US$57,791 		1,763 -6.1% 32.78 US$57,791
2020-08-20 2020-08-18 S Sale
3.2
Campagna Jason

Chief Medical Officer

Officer
1,192 -12.0%
47.44
US$56,543 		1,192 -12.0% 47.44 US$56,543
2020-08-17 2020-08-17 S Sale
3.8
Genextra S.p.A.
Large shareholder
1,235,512 -23.6%
46.75
US$57,760,186 		1,235,512 -23.6% 46.75 US$57,760,186
2020-08-17 2020-08-17 S Sale
3.8
Genextra S.p.A.
Large shareholder
126,888 -2.4%
50.15
US$6,362,913 		126,888 -2.4% 50.15 US$6,362,913
2020-08-17 2020-08-17 S Sale
3.8
Fundaro Paolo
Non-Executive Director Large shareholder
1,235,512 -23.6%
46.75
US$57,760,186 		1,235,512 -23.6% 46.75 US$57,760,186
2020-08-17 2020-08-17 S Sale
3.8
Fundaro Paolo
Non-Executive Director Large shareholder
126,888 -2.4%
50.15
US$6,362,913 		126,888 -2.4% 50.15 US$6,362,913
2020-08-17 2020-08-17 S Sale
3.8
Micheli Francesco
Large shareholder
1,235,512 -23.6%
46.75
US$57,760,186 		1,235,512 -23.6% 46.75 US$57,760,186
2020-08-17 2020-08-17 S Sale
3.8
Micheli Francesco
Large shareholder
126,888 -2.4%
50.15
US$6,362,913 		126,888 -2.4% 50.15 US$6,362,913
2020-08-17 2020-08-14 S Sale
3.8
Genextra S.p.A.
Large shareholder
54,600 -1.0%
50.55
US$2,760,112 		54,600 -1.0% 50.55 US$2,760,112
2020-08-17 2020-08-14 S Sale
3.8
Fundaro Paolo
Non-Executive Director Large shareholder
54,600 -1.0%
50.55
US$2,760,112 		54,600 -1.0% 50.55 US$2,760,112
2020-08-17 2020-08-14 S Sale
3.8
Micheli Francesco
Large shareholder
54,600 -1.0%
50.55
US$2,760,112 		54,600 -1.0% 50.55 US$2,760,112
2020-08-17 2020-08-13 S Sale
3.8
Fundaro Paolo
Non-Executive Director Large shareholder
83,000 -1.5%
52.60
US$4,365,451 		83,000 -1.5% 52.60 US$4,365,451
2020-08-17 2020-08-13 S Sale
3.8
Genextra S.p.A.
Large shareholder
83,000 -1.5%
52.60
US$4,365,451 		83,000 -1.5% 52.60 US$4,365,451
2020-08-17 2020-08-13 S Sale
3.8
Micheli Francesco
Large shareholder
83,000 -1.5%
52.60
US$4,365,451 		83,000 -1.5% 52.60 US$4,365,451
2020-05-15 2020-05-13 S Sale
3.8
Micheli Francesco
Large shareholder
595,578 -9.8%
84.60
US$50,385,899 		595,578 -9.8% 84.60 US$50,385,899
2020-05-15 2020-05-13 S Sale
3.8
Fundaro Paolo
Non-Executive Director Large shareholder
595,578 -9.8%
84.60
US$50,385,899 		595,578 -9.8% 84.60 US$50,385,899
2020-05-15 2020-05-13 S Sale
3.8
Genextra S.p.A.
Large shareholder
595,578 -9.8%
84.60
US$50,385,899 		595,578 -9.8% 84.60 US$50,385,899
2020-04-29 2020-04-27 PlS Planned sale
Weyer Christian

EVP, Research & Development

Officer
181 -1.0%
85.95
US$15,557 		181 -1.0% 85.95 US$15,557
2020-04-10 2020-04-09 PlS Planned sale
2.1
Ford David A

Chief Human Resources Officer

Officer
58 -0.4%
70.00
US$4,060 		58 -0.4% 70.00 US$4,060
2020-02-28 2020-02-27 PlS Planned sale
Weyer Christian

EVP, Research & Development

Officer
113 -0.6%
87.62
US$9,901 		113 -0.6% 87.62 US$9,901
2020-01-27 2020-01-27 PlS Planned sale
Weyer Christian

EVP, Research & Development
723 -3.9%
94.04
US$67,991 		723 -3.9% 94.04 US$67,991
2020-01-08 2020-01-07 PlS Planned sale
3.2
Campagna Jason

Chief Medical Officer
732 -10.4%
113.02
US$82,731 		732 -10.4% 113.02 US$82,731
2020-01-03 2019-12-31 PlS Planned sale
Pruzanski Mark

President & CEO

Executive Director
100 -0.0%
125.00
US$12,500 		100 -0.0% 125.00 US$12,500
2020-01-03 2019-12-31 PlS Planned sale
Cawkwell Gail

SVP, Med Affairs, Safety & PV
262 -1.4%
125.00
US$32,750 		262 -1.4% 125.00 US$32,750
2019-12-30 2019-12-27 PlS Planned sale Weyer Christian

EVP, Research & Development

Officer
1,581 -10.0%
123.24
US$194,842 		1,581 -10.0% 123.24 US$194,842
2019-12-30 2019-12-26 PlS Planned sale Cawkwell Gail

SVP, Med Affairs, Safety & PV

Officer
54 -0.3%
125.00
US$6,750 		54 -0.3% 125.00 US$6,750
2019-12-30 2019-12-26 PlS Planned sale Pruzanski Mark

President & CEO

Executive Director
417 -0.1%
125.00
US$52,125 		417 -0.1% 125.00 US$52,125
2019-12-20 2019-12-19 PlS Planned sale Campagna Jason

Chief Medical Officer

Officer
154 -2.0%
119.45
US$18,395 		154 -2.0% 119.45 US$18,395
2019-12-02 2019-11-27 PlS Planned sale Weyer Christian

EVP, Research & Development

Officer
1,040 -6.2%
101.65
US$105,716 		1,040 -6.2% 101.65 US$105,716
2019-11-27 2019-11-26 PlS Planned sale
Weyer Christian

EVP, Research & Development
4,373 -21.7%
100.00
US$437,300 		4,373 -21.7% 100.00 US$437,300
2019-11-27 2019-11-26 PlS Planned sale
Pruzanski Mark

President & CEO

Executive Director
35,437 -7.0%
100.00
US$3,543,700 		35,437 -7.0% 100.00 US$3,543,700
2019-11-27 2019-11-25 PlS Planned sale
Weyer Christian

EVP, Research & Development
1,855 -10.5%
100.00
US$185,500 		1,855 -10.5% 100.00 US$185,500
2019-11-27 2019-11-25 PlS Planned sale
Pruzanski Mark

President & CEO

Executive Director
14,563 -3.0%
100.00
US$1,456,300 		14,563 -3.0% 100.00 US$1,456,300
2019-11-19 2019-11-19 PlS Planned sale Weyer Christian

EVP, Research & Development

Officer
1,550 -9.0%
85.00
US$131,750 		1,550 -9.0% 85.00 US$131,750
2019-11-19 2019-11-19 PlS Planned sale Sullivan Ryan T

General Counsel and Secretary

Officer
3,829 -14.9%
85.00
US$325,465 		3,829 -14.9% 85.00 US$325,465
2019-11-19 2019-11-19 PlS Planned sale Sullivan Ryan T

General Counsel and Secretary

Officer
8,325 -24.5%
85.00
US$707,625 		8,325 -24.5% 85.00 US$707,625
2019-11-15 2019-11-13 PlS Planned sale Weyer Christian

EVP, Research & Development
946 -5.2%
85.00
US$80,410 		946 -5.2% 85.00 US$80,410
2019-11-15 2019-11-13 PlS Planned sale Sullivan Ryan T

General Counsel and Secretary
500 -1.9%
85.00
US$42,500 		500 -1.9% 85.00 US$42,500
2019-10-31 2019-10-29 PlS Planned sale
Bright Lisa

President, International
595 -3.1%
75.00
US$44,625 		595 -3.1% 75.00 US$44,625
2019-10-25 2019-10-23 PlS Planned sale
2.1
Ford David A

Chief Human Resources Officer
58 -0.5%
70.00
US$4,060 		58 -0.5% 70.00 US$4,060
2019-09-18 2019-09-16 PlS Planned sale
2.1
Ford David A

Chief Human Resources Officer
800 -6.5%
70.00
US$56,000 		800 -6.5% 70.00 US$56,000
2019-08-30 2019-08-28 B Purchase AKKARAJU SRINIVAS Non-Executive Director
5,207 +1.3%
60.32
US$314,086 		5,207 +1.3% 60.32 US$314,086
2019-07-03 2019-07-03 PlS Planned sale
Bright Lisa

President, International
595 -2.9%
78.66
US$46,803 		595 -2.9% 78.66 US$46,803
2019-05-14 2019-05-14 B Purchase
3.3
Benatti Luca
Non-Executive Director
1,200 +18.9%
83.50
US$100,200 		1,200 +18.9% 83.50 US$100,200
2019-05-03 2019-05-01 PlS Planned sale
Shapiro David

Chief Medical Officer

Officer
2,000 -4.8%
86.28
US$172,560 		2,000 -4.8% 86.28 US$172,560
2019-04-16 2019-04-15 PlS Planned sale
Shapiro David

Chief Medical Officer
2,000 -4.8%
95.00
US$190,000 		2,000 -4.8% 95.00 US$190,000
2019-04-03 2019-04-03 PlS Planned sale
Shapiro David

Chief Medical Officer
562 -1.4%
115.01
US$64,636 		562 -1.4% 115.01 US$64,636
2019-04-03 2019-04-03 PlS Planned sale
Bright Lisa

President, International
594 -2.8%
115.01
US$68,316 		594 -2.8% 115.01 US$68,316
2019-03-29 2019-03-29 PlS Planned sale
3.8
Fundaro Paolo
2,171 -16.3%
107.45
US$233,272 		2,171 -16.3% 107.45 US$233,272
2019-03-01 2019-03-01 PlS Planned sale
Weyer Christian

EVP, Research & Development

Officer
333 -1.7%
103.16
US$34,352 		333 -1.7% 103.16 US$34,352
2019-03-01 2019-03-01 PlS Planned sale
Shapiro David

Chief Medical Officer

Officer
2,000 -4.7%
103.16
US$206,320 		2,000 -4.7% 103.16 US$206,320
2019-02-21 2019-02-19 PlS Planned sale
3.6
AKKARAJU SRINIVAS
Non-Executive Director
23,438 -10.0%
128.78
US$3,018,346 		23,438 -10.0% 128.78 US$3,018,346
2019-02-20 2019-02-15 PlS Planned sale
Shapiro David

Chief Medical Officer

Officer
2,000 -4.7%
111.51
US$223,020 		2,000 -4.7% 111.51 US$223,020
2019-01-09 2019-01-07 PlS Planned sale
Bright Lisa

President, International

Officer
1,313 -6.5%
104.93
US$137,773 		1,313 -6.5% 104.93 US$137,773
2019-01-04 2019-01-04 PlS Planned sale
Shapiro David

Chief Medical Officer

Officer
474 -1.3%
97.48
US$46,206 		474 -1.3% 97.48 US$46,206
2020-01-03 2019-01-03 PlS Planned sale
2.1
Ford David A

Chief Human Resources Officer
259 -2.4%
117.16
US$30,344 		259 -2.4% 117.16 US$30,344
2019-01-03 2019-01-03 PlS Planned sale
Shapiro David

Chief Medical Officer

Officer
699 -1.8%
97.45
US$68,118 		699 -1.8% 97.45 US$68,118
2019-01-03 2019-01-02 PlS Planned sale
Shapiro David

Chief Medical Officer

Officer
2,000 -4.9%
98.28
US$196,560 		2,000 -4.9% 98.28 US$196,560
2018-12-19 2018-12-17 PlS Planned sale Shapiro David

Chief Medical Officer

Officer
2,000 -4.9%
106.62
US$213,240 		2,000 -4.9% 106.62 US$213,240
2018-12-06 2018-12-04 S Sale Bright Lisa

President, International

Officer
300 -1.4%
111.00
US$33,300 		300 -1.4% 111.00 US$33,300
2018-12-06 2018-12-03 S Sale Bright Lisa

President, International

Officer
200 -0.9%
113.22
US$22,645 		200 -0.9% 113.22 US$22,645
2018-12-06 2018-12-03 S Sale Bright Lisa

President, International

Officer
700 -3.1%
112.12
US$78,486 		700 -3.1% 112.12 US$78,486
2018-12-06 2018-12-03 S Sale Bright Lisa

President, International

Officer
3,800 -14.5%
111.23
US$422,691 		3,800 -14.5% 111.23 US$422,691
2018-12-03 2018-11-29 S Sale Genextra S.p.A.
750,000 -11.0%
105.07
US$78,802,500 		750,000 -11.0% 105.07 US$78,802,500
2018-12-03 2018-11-29 S Sale Micheli Francesco
750,000 -11.0%
105.07
US$78,802,500 		750,000 -11.0% 105.07 US$78,802,500
2018-11-29 2018-11-29 PlS Planned sale Weyer Christian

EVP, Research & Development

Officer
1,343 -7.8%
113.78
US$152,807 		1,343 -7.8% 113.78 US$152,807
2018-11-16 2018-11-16 PlS Planned sale Pruzanski Mark

President & CEO

Executive Director
1,988 -0.3%
103.29
US$205,333 		1,988 -0.3% 103.29 US$205,333
2018-11-16 2018-11-16 PlS Planned sale Pruzanski Mark

President & CEO

Executive Director
7,839 -1.4%
102.61
US$804,374 		7,839 -1.4% 102.61 US$804,374
2018-11-16 2018-11-16 PlS Planned sale Pruzanski Mark

President & CEO

Executive Director
7,949 -1.4%
101.48
US$806,687 		7,949 -1.4% 101.48 US$806,687
2018-11-16 2018-11-16 PlS Planned sale Pruzanski Mark

President & CEO

Executive Director
9,830 -1.7%
100.38
US$986,735 		9,830 -1.7% 100.38 US$986,735
2018-11-16 2018-11-15 PlS Planned sale Pruzanski Mark

President & CEO

Executive Director
3,521 -0.6%
101.13
US$356,088 		3,521 -0.6% 101.13 US$356,088
Explore more

More insider trading research around Intercept Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America